Home
Dong-A ST Co.

Dong-A ST Co. Market Share Analysis for August 2026

Health > Biotechnology and Pharmaceuticals

Domaindonga-st.com

Year Founded2013

Employees1001 - 5000

Annual Revenue$200M - $500M

Dong-A ST Co.

Dong-A ST Co. (including company regionals)

donga-st.com

See more website traffic and engagement information

Dong-A ST Co. Revenue up to August 2026 is 200M - 500M

revenue generated by Dong-A ST Co. top domains

Dong-A ST Co. top domains revenue over 3 years

Revenue for Dong-A ST Co. top domains

donga-st.com200M - 500M

See more with Sales Intelligence

Total visits to Dong-A ST Co.'s top domains

Understand Dong-A ST Co. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

donga-st.com9.1K

See more with Sales Intelligence

Avg. visit duration in Dong-A ST Co.'s top domains

Analyze Dong-A ST Co. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

donga-st.com00:00:32

See more with Sales Intelligence

Avg. pageviews on Dong-A ST Co.'s top domains

See how Dong-A ST Co. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

donga-st.com2.29

See more with Sales Intelligence

Dong-A ST Co. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

donga.co.krCompany NameDong-A Socio HoldingsEmployees1001 - 5000HQKorea, Republic of, SeoulAnnual revenue$200M - $500MTotal visits19.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Dong-A ST Co.

These are the website technologies, by industry, used by Dong-A ST Co. top domains

eCommerce (2)

Swap

Advertising (1)

DoubleClick

Audio Video Media (1)

YouTube

Conversion & Analytics (1)

Matomo (Previously Piwik)

More Technologies

4

See all

News & Signals from Dong-A ST Co.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDong-A ST partnered with Arrotex Pharmaceuticals Pty on Jun 11th '26.Korea-based Dong-A ST has entered into a licensing agreement with Arrotex Pharmaceuticals for its epilepsy treatment.

NewsDong-A ST is developing novel treatment for inflammatory bowel disease.Dong-A ST said it has partnered with the Korea Institute of Science and Technology (KIST) to develop a novel treatment for inflammatory bowel disease (IBD).